412 related articles for article (PubMed ID: 17597003)
1. Regulation of Yersinia Yop-effector delivery by translocated YopE.
Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
[TBL] [Abstract][Full Text] [Related]
2. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
Viboud GI; Mejía E; Bliska JB
Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of the YopE GTPase-activating protein (GAP) activity of Yersinia pseudotuberculosis.
Aili M; Isaksson EL; Hallberg B; Wolf-Watz H; Rosqvist R
Cell Microbiol; 2006 Jun; 8(6):1020-33. PubMed ID: 16681842
[TBL] [Abstract][Full Text] [Related]
4. The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity.
Håkansson S; Schesser K; Persson C; Galyov EE; Rosqvist R; Homblé F; Wolf-Watz H
EMBO J; 1996 Nov; 15(21):5812-23. PubMed ID: 8918459
[TBL] [Abstract][Full Text] [Related]
5. TyeA of Yersinia pseudotuberculosis is involved in regulation of Yop expression and is required for polarized translocation of Yop effectors.
Sundberg L; Forsberg A
Cell Microbiol; 2003 Mar; 5(3):187-202. PubMed ID: 12614462
[TBL] [Abstract][Full Text] [Related]
6. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation.
Francis MS; Wolf-Watz H
Mol Microbiol; 1998 Aug; 29(3):799-813. PubMed ID: 9723919
[TBL] [Abstract][Full Text] [Related]
7. YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane.
Holmström A; Petterson J; Rosqvist R; Håkansson S; Tafazoli F; Fällman M; Magnusson KE; Wolf-Watz H; Forsberg A
Mol Microbiol; 1997 Apr; 24(1):73-91. PubMed ID: 9140967
[TBL] [Abstract][Full Text] [Related]
8. TyeA, a protein involved in control of Yop release and in translocation of Yersinia Yop effectors.
Iriarte M; Sory MP; Boland A; Boyd AP; Mills SD; Lambermont I; Cornelis GR
EMBO J; 1998 Apr; 17(7):1907-18. PubMed ID: 9524114
[TBL] [Abstract][Full Text] [Related]
9. Yersinia enterocolitica can deliver Yop proteins into a wide range of cell types: development of a delivery system for heterologous proteins.
Boyd AP; Grosdent N; Tötemeyer S; Geuijen C; Bleves S; Iriarte M; Lambermont I; Octave JN; Cornelis GR
Eur J Cell Biol; 2000 Oct; 79(10):659-71. PubMed ID: 11089914
[TBL] [Abstract][Full Text] [Related]
10. Yersinia controls type III effector delivery into host cells by modulating Rho activity.
Mejía E; Bliska JB; Viboud GI
PLoS Pathog; 2008 Jan; 4(1):e3. PubMed ID: 18193942
[TBL] [Abstract][Full Text] [Related]
11. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence.
Black DS; Bliska JB
Mol Microbiol; 2000 Aug; 37(3):515-27. PubMed ID: 10931345
[TBL] [Abstract][Full Text] [Related]
12. ADP-ribosylation by exoenzyme T of Pseudomonas aeruginosa induces an irreversible effect on the host cell cytoskeleton in vivo.
Sundin C; Hallberg B; Forsberg A
FEMS Microbiol Lett; 2004 May; 234(1):87-91. PubMed ID: 15109724
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of type III effector translocation by Yersinia pseudotuberculosis expressing native LcrV or PcrV from Pseudomonas aeruginosa.
Bröms JE; Sundin C; Francis MS; Forsberg A
J Infect Dis; 2003 Jul; 188(2):239-49. PubMed ID: 12854079
[TBL] [Abstract][Full Text] [Related]
14. Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis.
Frithz-Lindsten E; Holmström A; Jacobsson L; Soltani M; Olsson J; Rosqvist R; Forsberg A
Mol Microbiol; 1998 Sep; 29(5):1155-65. PubMed ID: 9767584
[TBL] [Abstract][Full Text] [Related]
15. The membrane localization domain is required for intracellular localization and autoregulation of YopE in Yersinia pseudotuberculosis.
Isaksson EL; Aili M; Fahlgren A; Carlsson SE; Rosqvist R; Wolf-Watz H
Infect Immun; 2009 Nov; 77(11):4740-9. PubMed ID: 19687205
[TBL] [Abstract][Full Text] [Related]
16. The type III secretion chaperone LcrH co-operates with YopD to establish a negative, regulatory loop for control of Yop synthesis in Yersinia pseudotuberculosis.
Francis MS; Lloyd SA; Wolf-Watz H
Mol Microbiol; 2001 Nov; 42(4):1075-93. PubMed ID: 11737648
[TBL] [Abstract][Full Text] [Related]
17. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
Adams W; Morgan J; Kwuan L; Auerbuch V
Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
[TBL] [Abstract][Full Text] [Related]
18. A bacterial type III secretion system inhibits actin polymerization to prevent pore formation in host cell membranes.
Viboud GI; Bliska JB
EMBO J; 2001 Oct; 20(19):5373-82. PubMed ID: 11574469
[TBL] [Abstract][Full Text] [Related]
19. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments.
Frithz-Lindsten E; Du Y; Rosqvist R; Forsberg A
Mol Microbiol; 1997 Sep; 25(6):1125-39. PubMed ID: 9350868
[TBL] [Abstract][Full Text] [Related]
20. The RACK1 signaling scaffold protein selectively interacts with Yersinia pseudotuberculosis virulence function.
Thorslund SE; Edgren T; Pettersson J; Nordfelth R; Sellin ME; Ivanova E; Francis MS; Isaksson EL; Wolf-Watz H; Fällman M
PLoS One; 2011 Feb; 6(2):e16784. PubMed ID: 21347310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
